Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS-induced apoptosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 39, Issue 1, 2008, Pages 77-85

  Damico, Rachel L ^a   Chesley, Alan ^a   Johnston, Laura ^a   Bind, Eric P ^a   Amaro, Eric ^a   Nijmeh, Julie ^a   Karakas, Bedri ^b   Welsh, Laura ^a   Pearse, David B ^a   Garcia, Joe G N ^a   Crow, Michael T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apoptosis; Endothelial cells; FLICE like inhibitory protein; Macrophage migration inhibitory factor

Indexed keywords

FLICE INHIBITORY PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA INTERFERENCE;

APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DEATH; DNA PRIMERS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PULMONARY ARTERY; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 45849138799     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0248OC     Document Type: Article

References (54)

1. Clark I., Awburn M. Migration inhibitory factor in the cerebral and systemic endothelium in sepsis and malaria. Crit Care Med 2002;30:S263-S267.
2. Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001;29:S28-S34; discussion S34-S35.
3. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 2003;326:262-266.
4. Hotchkis RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
5. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;1456-1462.
6. Hiramatsu M, Hotchkiss RS, Karl IE, Buchman TG. Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 1997;7:247-253.
7. Fujita M, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T, Hara N. Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int Arch Allergy Immunology 1998;117:202-208.
8. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Maeyama T, Hara N. Protection from lethal apoptosis in lipopolysaccharide- induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 2000;157:597-603.
9. Papathanassoglou ED, Moynihan JA, Ackerman MH. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 2000;28:537-549.
10. Bannerman DD, Goldblum SE. Mechanisms of bacterial lipopolysaccharide- induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L899-L914.
11. Hoyt DG, Mannix RJ, Rusnak JM, Pitt BR, Lazo, JS. Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Physiol 1995;269:L171-L177.
12. Petrache I., Birokuv K, Zaiman AL, Crow MT, Deng H, Wadaonkar R, Romer LH, Garcia JGN. Caspase-dependent cleavage of myosin light chain kinase (MLCK) is involved in TNF-{alpha}-mediated bovine pulmonary endothelial cell apoptosis. FASEB J 2003;17:407-416.
13. Bannerman DD, Tupper JC, Ricketts WA, Bennett CF, Winn RK, Harlan JM.. A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem 2001;276:14924-14932.
14. Zen K, Karsan A, Stempien-Otero A, Yee E, Tupper J, Li X, Eunson T, M. Kay MA, Wilson CB, Winn RK, Harlan JM. NF-kappa B activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide. J Biol Chem 1999;274:28808-28815.
15. Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 2002;35:28-40.
16. Stehlik C, de Marti R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 1998;188:211-216.
17. Bannerman DD, Eiting KT, Winn RK, Harlan JM. FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Am J Pathol 2004;165:1423-1431.
18. Choi KB, Wong F, Harlan JM, Chaudhary, PM, Hood L, Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J Biol Chem 1998;273:20185-20188.
19. Hu X, Yee E, Harlan JM, Wong F, Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 1998;92:2759-2765.
20. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1991;5:181-191.
21. Yang Y, Degrandpre P, Kharfi A, Aloum A. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endrocrinol Metab 2000;85:4721-4727.
22. Baumann R., Casaultra C, Simon D, Conus S, Yousefi S, Simon HU. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 2003;17:2221-2230.
23. Li Y, Lu C, Xing G, Zhu Y, He F. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Exp Cell Res 2004;300:379-387.
24. Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, Chen Y, Jiang G, Lau C, Yu WC, Bache M, Fan ST. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 2003;107:22-29.
25. Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch, C, Evans S, Ibrahim H, Le QT, Terris DT, Giaccia AJ. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883-887.
26. Froidevaux C, Roger T, Martin C, Glauser MP, Calandra T. Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Crit Care Med 2001;29:S13-S15.
27. Munaut C, Boniver J, Foidart JM, Deprez M. Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol 2002;28:452-460.
28. Bacher M, Schrader J, Thompson N, Kuschela K, Gemsa D, Waeber G, Schlegel J. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am J Pathol 2003;162:11-17.
29. Erwert RD, Winn RK, Harlan JM, Bannerman DD. Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis. J Biol Chem 2002;277:40567-40574.
30. Wang X, Wang Y, Zhang J, Kim HP, Ryter SW, Choi AM. FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation. Mol Cell Biol 2005;25:4742-4751.
31. Budd RC, Yeh WC, Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 2006;6:196-204.
32. Poukkula M, Kaunisto A, Hietakangas V, Denessiouk K, Katajamaki T, Johnson, MS, Sistonen L, Eriksson JE. Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail. J Biol Chem 2005;280:27345-27355.
33. Shi X, Leng L, Wang T, Wang, W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006;25:595-606.
34. Nechushtan A, Smith CL, Hsu YT, Youle RJ. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 1999;18:2330-2341.
35. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004;95:957-970.
36. Amin, MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE . Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 2003;93:321-329.
37. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D, Wagner E, Braun A, Bernhagen J. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 2003;170:3337-3347.
38. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002;99:345-350.
39. Bannerman DD, Tupper JC, Erwert RD, Winn RK, Harlan JM. Divergence of bacterial lipopolysaccharide pro-apoptotic signaling downstream of IRAK-1. J Biol Chem 2002;277:8048-8053.
40. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, V Steiner, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-195.
41. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996;271:4961-4965.
42. Nam YJ, Mani K, ashton AW, Peng CF, Krishamurthy B, Hayakawa Y, Lee P. Korsmeyer SJ, Kitsis RN. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol Cell, 2004l 15:901-912.
43. Kataoka T, Budd RC, Holer N, Thome M Martinous R, Irmler M, Burns K, Hahna M, Kennedy N, Kovacsovics M, Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol, 2000;10:640-648.
44. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol, 2001;21:3964-3973.
45. Fukazawa T, Fujiwara T, Uno F, Teraishi Y, Kadowaki T, Itoshima T., Takata Y, Kagawa S, Roth JA, Tschopp J, Tanaka N. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene 2001;20:5225-5231.
46. Perez D, White E. E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S. J Virol 2003;77:2651-2662.
47. Kleemann R Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johanees FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Btunner H, Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000;408:211-216.
48. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature, 1990;398:160-165.
49. Bin L, Xiaoyan L, Xu L-G, Shu HB. The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis. FEBS Lett 2002;510:37-40.
50. Salon C, Eymin B, Micheau O, Chaoerot L, Plumas J, Brambilla C, Brambillam E, Gazzeri S. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ 2006;13:260-272.
51. Sharp DA, Lawrence DA, Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 2005;280:19401-19409.
52. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 2006:18:688-703.
53. Shen L, Hu J, Lu H, Wu M, Qin W, Wan D, Li YY, Gu J. The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER. FEBS Lett 2003;540:86-90.
54. Crow MT. Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes. Circ Res 2002;91:183-185.